Melphalan

Melphalan is a chemotherapy medication used to treat certain types of cancer, such as multiple myeloma and ovarian cancer. It belongs to a class of drugs called alkylating agents, which work by interfering with the growth of cancer cells. Melphalan is usually given in combination with other medications or after a stem cell transplant. Common side effects include hair loss, nausea, vomiting, and decreased blood cell counts.

Melphalan is a powerful chemotherapy medication used to treat various cancers. Here's a breakdown of its key aspects:

Function:

  • Targets rapidly dividing cells: Melphalan works by interfering with DNA replication, a crucial process for cell growth and division. This disrupts the growth and spread of cancer cells, which tend to divide rapidly.

Treatment Use:

  • Multiple Cancers: Melphalan is used to treat various types of cancer, including:
    • Multiple myeloma: A cancer of the bone marrow that affects plasma cells, a type of white blood cell.
    • Ovarian cancer
    • Breast cancer (less commonly used now)
    • Melanoma (advanced stages)
  • Combination therapy: Melphalan is often used in combination with other chemotherapy drugs to create a more effective treatment regimen.

Administration:

  • Different routes: Melphalan can be administered through different routes depending on the specific treatment plan. This may include:
    • Intravenous injection (IV): This is the most common route for Melphalan administration.
    • High-dose chemotherapy with stem cell transplant: In some cases, high-dose Melphalan may be used as part of a high-dose chemotherapy regimen followed by stem cell transplantation for multiple myeloma.
    • Topical application: For certain skin cancers, a topical cream containing Melphalan might be used.

Important Considerations:

  • Strong medication: Melphalan is a potent medication that can cause severe side effects. These can include:
    • Bone marrow suppression: This can lead to a decrease in red blood cells (anemia), white blood cells (increased risk of infection), and platelets (increased risk of bleeding).
    • Nausea and vomiting
    • Hair loss
    • Fatigue
    • Increased risk of infections
    • Lung problems
    • Infertility
  • Close monitoring: Due to the potential side effects, patients receiving Melphalan require close monitoring by healthcare professionals throughout treatment.
  • Pregnancy and breastfeeding: Melphalan can cause birth defects and should not be used during pregnancy. It's also not recommended during breastfeeding.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01A - Alkylating agents
L01AA Nitrogen mustard analogues
External Links